Clinical Trial Update: VX-950HEP1001 - Drug-drug Interaction Study Between Telaprevir and Raltegravir [Phase 1]

View source ↗

Summary

This document reports the completion of a Phase 1 drug-drug interaction study evaluating the combination of telaprevir and raltegravir for Hepatitis C.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Incivek (Telaprevir) (Telaprevir)
• Isentress (Raltegravir) (Raltegravir)

Snippet

Sponsor: Tibotec BVBA | Conditions: Hepatitis C | Phase 1 | Status: COMPLETED